Ocrevus (ocrelizumab)

November 2, 2017November 1, 2017

Ocrevus Q&A, Part 1

Columns, Engaging Thoughts

Editor’s Note: First in a two-part series on readers’ comments about Ocrevus (ocrelizumab). I switched disease-modifying therapies and began treatment with Ocrevus (ocrelizumab) in June. I previously ... Read more

August 31, 2017August 30, 2017

Ocrevus and Sweating Out MS

Columns, Engaging Thoughts

Many of you are considering making the switch to Ocrevus (ocrelizumab) as your disease-modifying therapy for multiple sclerosis. This is a switch I made recently. There ... Read more

July 13, 2017July 13, 2017

Ocrevus and Me, Part 2: Infusion Time and Side Effects

Columns, Engaging Thoughts

Editor’s note: This column is second in a series. Read the first part here. Just you wait! How many times have we heard those words or ... Read more

July 10, 2017July 10, 2017

MS News That Caught My Eye: Young Patients Quit DMDs, Antioxidant to Slow Brain Decline, Interview with Top Ocrevus Doc, and Why Don’t I Smell That?

Columns, The MS Wire - A Column by Ed Tobias

In case you missed them, here are some news stories that appeared in MS News Today that caught my eye over the past week. Younger MS Patients ... Read more

July 6, 2017July 5, 2017

Ocrevus and Me

Columns, Engaging Thoughts

I’ve done it! I made the treatment switch that so many people with multiple sclerosis are talking about: I said goodbye to Tysabri (natalizumab) and am ... Read more

June 23, 2017June 22, 2017

Ocrevus, Hope, and a Suicide Postponed

Columns, The MS Wire - A Column by Ed Tobias

Several months ago, I wrote a column about Andrew Barclay. Barclay died in an assisted suicide in December. He’d had multiple sclerosis for many years. Colin ... Read more

April 20, 2017

5 Things To Know About Ocrevus Dosage

The multiple sclerosis community is buzzing with news of the recent FDA approval of the drug Ocrevus (ocrelizumab) which can be used in the treatment of ... Read more

April 12, 2017April 13, 2017

Ocrevus Approval: A Quick Cheat Sheet

The multiple sclerosis (MS) community has been busy talking about the recently FDA-approved drug Ocrevus (ocrelizumab). It’s been proven to slow down the progression of the disease, but ... Read more

April 11, 2017April 11, 2017

Need Help Paying for Your MS Drug?

Columns, The MS Wire - A Column by Ed Tobias

With last month’s approval of the multiple sclerosis drug Ocrevus, I’ve again heard the plea “But how can I afford it?” Ocrevus carries a price tag ... Read more

April 7, 2017April 6, 2017

Ocrevus: Should I Switch?

Columns, The MS Wire - A Column by Ed Tobias

There was much fanfare when the multiple sclerosis drug Ocrevus (ocrelizumab) finally was approved by the U.S. Food and Drug Administration last week. Perhaps a little ... Read more

April 6, 2017June 19, 2017

Ohio State Neurologist Shares Insight About MS B-Cell Therapy Ocrevus

Columns, Engaging Thoughts

A prominent neurologist, who was involved in early research into B-cell therapy, tells Multiple Sclerosis News Today about his positive experience of using ocrelizumab, now branded Ocrevus, ... Read more

April 4, 2017April 4, 2017

Ocrevus: FDA Approval Triggers Hope, Optimism — and Concern — Among MS Patients

Columns, Patiently Awakened - A Column by Teresa Wright-Johnson

The past few days have been remarkable in the multiple sclerosis (MS) community, with the U.S. Food and Drug Administration (FDA) approving Ocrevus to treat relapsing ... Read more